EI
STIM icon

EAM Investors’s Neuronetics STIM Stock Holding History

EAM Investors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-104,597
Closed -$385K – 343
2025
Q1 		$385K Buy
+104,597
New +$382K 0.07% 239
2023
Q1 		– Sell
-302,560
Closed -$2.08M – 360
2022
Q4 		$2.08M Buy
+302,560
New +$1.43M 0.43% 89
2018
Q4 		– Sell
-22,479
Closed -$721K – 319
2018
Q3 		$721K Buy
+22,479
New +$683K 0.11% 270

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

EAM Investors's STIM Position: Q2 2025 in Review

EAM Investors sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 104,597 shares — an estimated $385K sold.

EAM Investors first reported a position in STIM in Q3 2018 and held it in 3 quarters. The position peaked at $2.08M in Q4 2022. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • EAM Investors reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • EAM Investors sold 104,597 Neuronetics shares in Q2 2025, an estimated $385K.
  • EAM Investors first reported a position in Neuronetics in Q3 2018 and held it in 3 quarters.
  • EAM Investors's Neuronetics position peaked at $2.08M in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.